Dec 8, 2024, 13:13
Biochemical Response to ADT and Mortality Risk in Prostate Cancer – ACS Journal Cancer
ACS Journal Cancer shared a post on X, about a recent paper by Mutlay Sayan et al. published in Cancer Journal:
“This new study from Dana-Farber’s Radiation Oncology researchers validates that a PSA level >0.5 ng/mL after neoadjuvant ADT and before RT is prognostic and significantly associated with an increased ACM risk.”
Authors: Mutlay Sayan, Ming-Hui Chen, Jing Wu, Jonathan Leeman, Shalini Moningi, Martin King, Peter Orio, Paul Nguyen, Anthony D’Amico.
More posts featuring ACS Journal Cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 8, 2024, 13:12
Dec 8, 2024, 13:07
Dec 8, 2024, 13:05
Dec 8, 2024, 13:05
Dec 8, 2024, 13:02
Dec 8, 2024, 12:58
Dec 8, 2024, 12:57
Dec 8, 2024, 12:51